Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > You PUMPERS are delusional at BEST.

<< Previous

Bullboard Posts

Next >>

Post by GreatGabboon Oct 03, 2021 7:52am

174 Views

Post# 33958426

You PUMPERS are delusional at BEST.

One day you'll have to accept it, this GARBAGE was never going anywhere and you're never getting your money back. Bob played us ALL with the "letter to investors" begging for you to

***B E L I E V E***

in his garbage lies and baseless business proposals. This was literally GVHD Kaly days 2.0 and nothing more. There was no value, there still is no value, and there will NEVER be any value.

Sorry but I'm so happy I sold at $0.55 a month ago and ran away from this JUNK. It's finished but you guys go ahead and believe whatever you want.